• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    7/10/23 1:50:32 PM ET
    $STRC
    $TCBP
    $TEAF
    $TGL
    Wholesale Distributors
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRC alert in real time by email

     

    On Monday, 65 companies hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).
    • The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX).
    • Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser.
    • Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%.
    • Humana (NYSE:HUM) shares reached a new 52-week low of $427.21 on Monday morning, moving up 0.06%.
    • Amcor (NYSE:AMCR) stock hit a new 52-week low of $9.48. The stock was down 3.77% on the session.
    • FMC (NYSE:FMC) stock hit $88.80 on Monday morning, setting a new 52-week low for a change of down 14.62%.
    • KT (NYSE:KT) shares fell to $11.10 on Monday, setting a new 52-week low with a shift of up 0.04%.
    • UGI (NYSE:UGI) shares were down 0.81% for the day, having made a 52-week low of $25.69.
    • Clearway Energy (NYSE:CWEN) shares moved down 0.29% on Monday to hit a new 52-week low of $27.38, drifting down 0.29%.
    • California Water Servs Gr (NYSE:CWT) shares set a new yearly low of $49.27 this morning. The stock was down 0.37% on the session.
    • SunPower (NASDAQ:SPWR) stock hit a new 52-week low of $8.99. The stock was up 1.49% on the session.
    • Northwest Natural Hldg (NYSE:NWN) shares reached a new 52-week low of $41.64 on Monday morning, moving up 0.12%.
    • Duckhorn Portfolio (NYSE:NAPA) stock broke to a new 52-week low of $12.54 on Monday. Shares of the company traded down 1.41%.
    • Kenon Hldgs (NYSE:KEN) stock achieved a new 52-week low on Monday morning, hitting $22.85 and moving down 2.52%.
    • Enanta Pharma (NASDAQ:ENTA) shares were up 1.69% for the day, having made a 52-week low of $19.29.
    • Chijet Motor Co (NASDAQ:CJET) stock achieved a new 52-week low on Monday morning, hitting $2.31 and moving 0.0% (flat).
    • First Foundation (NASDAQ:FFWM) shares made a new 52-week low of $3.75 on Monday. The stock was down 0.52% for the day.
    • Douglas Elliman (NYSE:DOUG) shares were up 5.6% for the day, having made a 52-week low of $2.07.
    • Tortoise Essential Assets (NYSE:TEAF) shares moved down 0.32% on Monday to hit a new 52-week low of $12.20, drifting down 0.32%.
    • Delaware Inv Natl Muni (AMEX:VFL) shares fell to $9.85 on Monday, setting a new 52-week low with a shift of down 0.2%.
    • OptiNose (NASDAQ:OPTN) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Cherry Hill Mortgage (NYSE:CHMI) shares fell to $4.33 on Monday, setting a new 52-week low with a shift of down 0.23%.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares moved up 1.24% on Monday to hit a new 52-week low of $2.38, drifting up 1.24%.
    • Jerash Holdings (US) (NASDAQ:JRSH) stock dropped to a yearly low on Monday of $3.64. Shares traded down 1.35%.
    • 22nd Century Group (NASDAQ:XXII) shares hit a yearly low of $2.42. The stock was down 7.47% on the session.
    • Interactive Strength (NASDAQ:TRNR) shares fell to $2.49 on Monday, setting a new 52-week low with a shift of up 3.44%.
    • Sarcos Technology (NASDAQ:STRC) stock hit $1.46 on Monday morning, setting a new 52-week low for a change of down 6.23%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.27. The stock was down 7.64% on the session.
    • Psychemedics (NASDAQ:PMD) shares set a new 52-week low of $4.19. The stock traded up 0.46%.
    • Tattooed Chef (NASDAQ:TTCF) shares reached a new 52-week low of $0.21 on Monday morning, moving down 11.54%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 2.25%.
    • Cineverse (NASDAQ:CNVS) stock hit a yearly low of $1.53. The stock was down 3.4% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.90 on Monday, setting a new 52-week low with a shift of down 3.29%.
    • Avalon Globocare (NASDAQ:ALBT) stock set a new 52-week low of $1.19 on Monday, moving up 6.19%.
    • ABVC BioPharma (NASDAQ:ABVC) shares set a new 52-week low of $0.44. The stock traded down 2.06%.
    • FOXO Technologies (AMEX:FOXO) shares moved down 7.27% on Monday to hit a new 52-week low of $0.18, drifting down 7.27%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Monday of $0.70. Shares traded down 3.1%.
    • T Stamp (NASDAQ:IDAI) shares were down 5.37% for the day, having made a 52-week low of $0.96.
    • iSun (NASDAQ:ISUN) shares set a new 52-week low of $0.37. The stock traded down 1.19%.
    • Ault Alliance (AMEX:AULT) shares fell to $4.86 on Monday, setting a new 52-week low with a shift of down 1.78%.
    • Enservco (AMEX:ENSV) stock broke to a new 52-week low of $0.29 on Monday. Shares of the company traded up 2.07%.
    • OceanPal (NASDAQ:OP) stock broke to a new 52-week low of $1.26 on Monday. Shares of the company traded down 7.56%.
    • SuperCom (NASDAQ:SPCB) shares made a new 52-week low of $0.92 on Monday. The stock was up 0.36% for the day.
    • Ra Medical Systems (AMEX:RMED) shares set a new 52-week low of $0.70. The stock traded down 5.47%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares moved up 1.99% on Monday to hit a new 52-week low of $0.50, drifting up 1.99%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $1.05. The stock was down 5.65% on the session.
    • Ucommune International (NASDAQ:UK) shares made a new 52-week low of $0.50 on Monday. The stock was up 1.63% for the day.
    • G Medical Innovations (NASDAQ:GMVD) shares made a new 52-week low of $0.32 on Monday. The stock was up 1.73% for the day.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new 52-week low of $0.43. The stock traded down 1.97%.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 2.76% for the day, having made a 52-week low of $3.76.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $STRC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRC
    $TCBP
    $TEAF
    $TGL

    CompanyDatePrice TargetRatingAnalyst
    Enanta Pharmaceuticals Inc.
    $ENTA
    11/14/2025Overweight
    Analyst
    Pfizer Inc.
    $PFE
    11/13/2025$30.00Sector Outperform
    Scotiabank
    Bristol-Myers Squibb Company
    $BMY
    11/13/2025$45.00Sector Perform
    Scotiabank
    FMC Corporation
    $FMC
    11/11/2025$16.00Equal Weight
    Wells Fargo
    Cherry Hill Mortgage Investment Corporation
    $CHMI
    11/6/2025$2.75Mkt Perform → Mkt Outperform
    Citizens JMP
    First Foundation Inc.
    $FFWM
    11/3/2025$6.75Neutral → Overweight
    Piper Sandler
    FMC Corporation
    $FMC
    10/31/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    FMC Corporation
    $FMC
    10/31/2025$16.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $STRC
    $TCBP
    $TEAF
    $TGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    SEC Filings

    View All

    Cineverse Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Cineverse Corp. (0001173204) (Filer)

    11/21/25 5:28:41 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Blue Star Foods Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Blue Star Foods Corp. (0001730773) (Filer)

    11/21/25 5:27:21 PM ET
    $BSFC

    Avalon GloboCare Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Avalon GloboCare Corp. (0001630212) (Filer)

    11/21/25 4:30:51 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

    PADCEV plus Keytruda is the first and only approved perioperative treatment regimen that can significantly improve survival over current standard of care (surgery alone) in cisplatin-ineligible patients with muscle-invasive bladder cancer Approval is based on unprecedented data from the pivotal Phase 3 EV-303 trial showing a 60% reduction in the risk of disease recurrence, progression or death and a 50% reduction in the risk of death compared to surgery alone Represents the first and only ADC and PD-1 inhibitor regimen for this patient population and a potential new standard of care Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Aste

    11/21/25 1:24:00 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UGI Reports Strong Fiscal 2025 Results

    Issues Fiscal 2026 Guidance UGI Corporation (NYSE:UGI) today reported financial results for the fiscal year ended September 30, 2025 and provided guidance for fiscal year 2026. HEADLINES GAAP net income of $678 million and adjusted net income of $728 million compared to GAAP net income of $269 million and adjusted net income of $658 million in the prior year. GAAP diluted earnings per share ("EPS") of $3.09 and adjusted diluted EPS of $3.32 compared to GAAP diluted EPS of $1.25 and adjusted diluted EPS of $3.06 in the prior year. Reportable segments earnings before interest expense and income tax1 ("EBIT") of $1,176 million compared to $1,178 million in the prior year. Deliv

    11/20/25 5:30:00 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    Greenwave Announces Receipt of a Staff Determination Letter from Nasdaq and That it Will Seek a Hearing & Continued Listing

    Chesapeake, VA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that, on November 18, 2025, the Company received a Staff Determination Letter (the "Staff Determination Letter") from the Nasdaq Listing Qualifications Staff (the "Staff") based on the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Rule"), as previously notified by the Staff on May 23, 2025, and August 22, 2025. The basis for the Staff Determination Letter is that the Company has not yet filed its Quarterly Reports on Form 10-Q for the p

    11/20/25 4:35:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    $STRC
    $TCBP
    $TEAF
    $TGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Enanta Pharmaceuticals

    Analyst initiated coverage of Enanta Pharmaceuticals with a rating of Overweight

    11/14/25 11:26:32 AM ET
    $ENTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scotiabank initiated coverage on Pfizer with a new price target

    Scotiabank initiated coverage of Pfizer with a rating of Sector Outperform and set a new price target of $30.00

    11/13/25 9:16:05 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scotiabank initiated coverage on Bristol-Myers with a new price target

    Scotiabank initiated coverage of Bristol-Myers with a rating of Sector Perform and set a new price target of $45.00

    11/13/25 9:12:36 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Long Nicholas T. bought $85,374 worth of Ordinary Shares (10,000 units at $8.54), increasing direct ownership by 19% to 62,911 units (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    11/14/25 4:03:10 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Director Raines John Mitchell bought $96,390 worth of shares (7,000 units at $13.77), increasing direct ownership by 103% to 13,784 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/14/25 9:19:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    Director Glerum James T Jr. bought $499,947 worth of Ordinary Shares (59,945 units at $8.34) (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    11/12/25 4:13:01 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & General Counsel Shao Wei-Ming exercised 5,200 shares at a strike of $69.12 and sold $1,045,252 worth of shares (5,200 units at $201.01) (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    11/20/25 4:30:03 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    VP & CAO Montgomery Jeanine converted options into 100 shares and sold $8,968 worth of shares (43 units at $208.55), increasing direct ownership by 0.66% to 8,733 units (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    11/19/25 4:55:57 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    SEC Form 4 filed by EXECUTIVE VP, FINANCE & CFO Casamento Michael

    4 - Amcor plc (0001748790) (Issuer)

    11/19/25 4:07:58 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    Leadership Updates

    Live Leadership Updates

    View All

    Trust Stamp selected for Trust Village 2026 Programme in Switzerland

    Atlanta, GA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI): Trust Stamp, a global provider of AI-powered software solutions focused on identity and trust, today announced its selection for the 2026 Trust Village Incubator, an initiative powered by EPFL Innovation Park, Trust Valley, SICPA and Canton de Vaud.The selection recognizes Trust Stamp's pioneering work in privacy-preserving identity technology, particularly its latest innovation, StableKey™, built upon the company's patented Stable IT2 cryptosystem. The StableKey solution introduces a groundbreaking approach to biometric authentication by enabling secure identity verification without storing any sensitive biometric d

    11/20/25 9:35:00 AM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    Douglas Elliman Real Estate Appoints Wendy Purvey as Chief Strategy Officer

    A 30-year-plus industry veteran, Purvey will spearhead strategic initiatives to fuel the company's long-term growth and drive revenue generation. NEW YORK, Nov. 12, 2025 /PRNewswire/ -- Douglas Elliman Realty, LLC ("Douglas Elliman"), one of the largest residential real estate brokerages in the country with the highest national average sales price, announced today that it has appointed Wendy S. Purvey to the role of Chief Strategy Officer. In this new role, Purvey will spearhead growth and revenue-generation initiatives, including supporting mergers and acquisitions, international partnerships, launching ancillary services opportunities, and optimizing agent retention.

    11/12/25 4:00:00 PM ET
    $DOUG
    Real Estate
    Finance

    Douglas Elliman Real Estate Names Chris Reyes Chief Technology Officer

    NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Douglas Elliman Realty, LLC ("Douglas Elliman"), one of the largest independent residential real estate brokerages in the United States, today announced the appointment of Chris Reyes as Chief Technology Officer. Mr. Reyes joins Douglas Elliman from Brown Harris Stevens where he served as CTO. In his new role, Reyes will oversee Douglas Elliman's technology team, infrastructure, product launch, and software development across all regions nationally. He brings more than two decades of experience innovating enterprise platforms and service

    11/11/25 11:00:00 AM ET
    $DOUG
    Real Estate
    Finance

    $STRC
    $TCBP
    $TEAF
    $TGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Financials

    Live finance-specific insights

    View All

    UGI Reports Strong Fiscal 2025 Results

    Issues Fiscal 2026 Guidance UGI Corporation (NYSE:UGI) today reported financial results for the fiscal year ended September 30, 2025 and provided guidance for fiscal year 2026. HEADLINES GAAP net income of $678 million and adjusted net income of $728 million compared to GAAP net income of $269 million and adjusted net income of $658 million in the prior year. GAAP diluted earnings per share ("EPS") of $3.09 and adjusted diluted EPS of $3.32 compared to GAAP diluted EPS of $1.25 and adjusted diluted EPS of $3.06 in the prior year. Reportable segments earnings before interest expense and income tax1 ("EBIT") of $1,176 million compared to $1,178 million in the prior year. Deliv

    11/20/25 5:30:00 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    UGI Declares Common Dividend

    The Board of Directors of UGI Corporation (NYSE: UGI) has declared a quarterly dividend of $0.375 per share of UGI's common stock. The dividend is payable January 1, 2026, to shareholders of record as of December 15, 2025. About UGI UGI Corporation (NYSE:UGI) is a distributor and marketer of energy products and services in the US and Europe. UGI offers safe, reliable, affordable, and sustainable energy solutions to customers through its subsidiaries, which provide natural gas transmission and distribution, electric generation and distribution, midstream services, propane distribution, renewable natural gas generation, distribution and marketing, and energy marketing services. Comprehens

    11/20/25 4:15:00 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    Treasure Global Acquires Quarters Elite to Accelerate OXI Wallet Scale-Up, Unlocking Up to USD 150 Million Revenue Opportunity

    KUALA LUMPUR, Malaysia, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ:TGL) ("Treasure Global" or the "Company"), a Southeast Asia–anchored technology company, today announced the acquisition of Quarters Elite Advisory Sdn Bhd ("Quarters Elite"), a Malaysian financial advisory firm managing approximately USD 150 million in client assets through a nationwide network of more than 350 professional financial consultants serving nearly 3,000 clients. The acquisition adds established revenue streams to Treasure Global and strengthens the Company's OXI Wallet commercialization strategy by providing a cost-efficient channel for user acquisition and engagement across Southeast Asia.

    11/20/25 10:10:00 AM ET
    $TGL
    Real Estate